Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | — |
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | SRC |
| 02 Oct 2025 | Olivér Várhelyi Commissioner | All pressing portfolio topics | SRC |
| 02 Jul 2025 | Sandra Gallina Director-General | EU pharmaceutical regulation and policy | — |
| 02 Jul 2025 | Sandra Gallina Director-General | EU pharmaceutical regulation and policy | SRC |
| 01 Jul 2025 | Vilija Sysaite Cabinet member | Parallel imports Pharmaceutical legislation | SRC |
| 01 Jul 2025 | Vilija Sysaite Cabinet member | Parallel imports Pharmaceutical legislation | — |
| 17 Jun 2025 | Dorota Denning Cabinet member | Simplification agenda and competitiveness | — |
| 17 Jun 2025 | Dorota Denning Cabinet member | Simplification agenda and competitiveness | SRC |
| 08 Mar 2023 | Simon Genevaz Cabinet member | Revision of the Pharmaceutical Package | SRC |
| 08 Mar 2023 | Simon Genevaz Cabinet member | Revision of the Pharmaceutical Package | — |
| 07 Mar 2023 | Peter Van Kemseke Cabinet member | EU pharmaceutical legislation-and discuss specifications the Environmental Risk Assessment (ERA) | SRC |
| 07 Mar 2023 | Peter Van Kemseke Cabinet member | EU pharmaceutical legislation-and discuss specifications the Environmental Risk Assessment (ERA) | — |
| 07 Mar 2023 | Joanna Stawowy Cabinet member | Upcoming revision of the EU pharmaceutical legislation; the critical point of the public service obligation proposed for manufacturers (Article 39(2)); the need for a European level public service obligation; the electronic patient leaflet; | SRC |
| 07 Mar 2023 | Joanna Stawowy Cabinet member | Upcoming revision of the EU pharmaceutical legislation; the critical point of the public service obligation proposed for manufacturers (Article 39(2)); the need for a European level public service obligation; the electronic patient leaflet; | — |
| 20 Mar 2022 | Karolina Herbout-Borczak Cabinet member | The upcoming revision of the EU pharmaceutical legislation. | SRC |
| 20 Mar 2022 | Karolina Herbout-Borczak Cabinet member | The upcoming revision of the EU pharmaceutical legislation. | — |
| 02 Feb 2021 | Pauline Weinzierl Cabinet member | Resilience of the EU pharmaceutical supply chain | — |
| 02 Feb 2021 | Eszter Batta Cabinet member | Resilience of the EU pharmaceutical supply chain | — |
| 02 Feb 2021 | Pauline Weinzierl Cabinet member | Resilience of the EU pharmaceutical supply chain | SRC |
| 02 Feb 2021 | Eszter Batta Cabinet member | Resilience of the EU pharmaceutical supply chain | SRC |
| 28 Aug 2018 | Kaius Kristian Hedberg Cabinet member | pharma sector - medicines | SRC |
| 28 Aug 2018 | Kaius Kristian Hedberg Cabinet member | pharma sector - medicines | — |
| 18 Jul 2018 | Annika Nowak Cabinet member | Parallel import of medicines | SRC |
| 18 Jul 2018 | Annika Nowak Cabinet member | Parallel import of medicines | — |
Mission & Goals
Affordable Medicines Europe represents Europe’s licensed parallel distribution industry, an integral part of the European pharmaceutical market that adds value to society by introducing price competition – especially for patented medicines – and a supplementary layer of product safety. In this our members work every day to make medicines more affordable for European healthcare systems and patients. Our industry has an annual turnover of 7.7 billion Euro. Through the direct membership of 15 national associations and individual companies, Affordable Medicines Europe's has 105 member companies in 21 EU and EEA Member States and the UK. These members account for approximately 80% of the total parallel import market volume in the area. Membership of Affordable Medicines Europe is exclusive to companies holding a wholesale (GDP) license (export and import). All importing members furthermore are GMP licensed.
EU Legislative Interests
Revision of the EU Pharma Package Critical Medicines Act Initiatives related to Single Market, including the Single market stragegy Implementation of the Directive on Falsified Medicines EMA - regulation impacting the parallel distribution of medicines EU competition rules EU rules regarding medical devices
Communication Activities
Social media posts Occasional events @FillTheGap media campaign
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Affordable Medicines Europe is a member of: - the European Medicines Verification Organisation (EMVO) - the Alliance for Safe Online Pharmacy (ASOP EU) - the Federation of European and International Associations (FAIB) - Friends of Europe - European Society of Association Executives (ESAE)
Organisation Members
https://affordablemedicines.eu/members/